70% off women and girl's apparel from Lilly Pulitzer. Dresses. Accessories. Shorts. Tops. Blouses. Pants. Children's sizes available. Authentic American Resortwear inspired by Palm Beach for ...

Lilly's shares fall 8% as drug sales miss expectations CEO David Ricks cited physical and financial constraints at wholesalers for the shortfall Lilly slashes annual profit forecast due to ...

One of the most affordable items in the House of Marley lineup is also a best-seller. The Smile Jamaica wired headphones are on sale for just $16 and you can get them in a range of different ...

Available now is this modern, spacious three bedroom townhouse conveniently located within walking distance to the town center of Sale, this beautifully presented home has everything you've been ...

Eli Lilly shares slid after the drugmaker reported disappointing quarterly results, with sales of its popular diabetes and anti-obesity drugs lower than expected. Lilly said inventory decreases by ...

Shares of Eli Lilly and Co. slumped toward their biggest ... due to big misses in sales of anti-obesity drugs Mounjaro and Zepbound. The company said sales of Mounjaro and Zepbound were hurt ...

Adjusted EPS of $1.18 was barely half of the $2.18 expected. Weight-Loss Drugs Have Powered Lilly, Novo Nordisk Results Surging sales for the weight-loss drugs have boosted Eli Lilly and Novo ...

(Bloomberg) -- Eli Lilly & Co. lowered its full-year guidance Wednesday after sales of its blockbuster weight-loss drug fell short of expectations, which the company blamed on inventory issues. Listen ...

Wednesday’s dive came as Eli Lilly’s results released at about 7 a.m. EDT were worse than analyst expectations across the board, headlined by its $11.4 billion in Q3 sales (5% below forecasts ...

Zepbound sales reached $1.26 billion. Trulicity sales fell 22% to $1.30 billion. Guidance: Eli Lilly forecasts fiscal year 2024 sales of $45.4 billion—$46 billion, compared to prior guidance of ...

Zepbound sales reached $1.26 billion. Trulicity sales fell 22% to $1.30 billion. Guidance: Eli Lilly forecasts fiscal year 2024 sales of $45.4 billion—$46 billion, compared to prior guidance of $45.4 ...